Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation vs Folic Acid for Hyperhomocysteinemia in CKD
NCT06847139Recruiting
- Sponsor
- Chattogram Medical College
- Start
- Jul 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of zinc in hyperhomocysteinemia (2 arms), sponsored by Chattogram Medical College. Primary endpoint: Change from baseline plasma homocysteine level at 6 weeks. Started Jul 2024; status: recruiting.
02
Drugs
zinc
03
Conditions
hyperhomocysteinemia
Beyond the preview
Go deeper on NCT06847139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06847139.